BEFOVACIMAB
UNII 8FFQ0L4R3B

Substance Identification & Data

This profile provides standardized clinical and technical data for Befovacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8FFQ0L4R3B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2156634-62-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8FFQ0L4R3B
CAS Registry Number
2156634-62-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BEFOVACIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171827
National Cancer Institute reference terminology for clinical and research data.
INN ID
11125
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Befovacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEFOVACIMAB

Common Names & Synonyms

BEFOVACIMAB [INN]
HUMAN TISSUE FACTOR PATHWAY INHIBITOR-NEUTRALIZING ANTIBODY (BAY 1093884)
IMMUNOGLOBULIN G2, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL 1093884 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 1093884 .LAMBDA.-CHAIN, DIMER

Technical Codes

BAY1093884
BAY-1093884

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus